Short answer
Fulgent Genetics, Inc. (FLGT) filed an 8-K current report with the SEC on May 14, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders approved the 2026 Equity Incentive Plan on May 14, 2026, replacing the Prior Plan.
Fulgent Genetics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Stockholders approved the 2026 Equity Incentive Plan on May 14, 2026, replacing the Prior Plan
- 2026 Plan authorizes 2,000,000 new common shares for employee equity awards
- Up to 1,500,000 additional shares available if Prior Plan awards are forfeited or cancelled
- Existing Prior Plan awards remain outstanding, but no new grants permitted after May 14, 2026
- Potential shareholder dilution from expanded equity compensation capacity; full terms in Exhibit 10.1
Item 5.07 · Submission of Matters to a Vote of Security Holders
- 83% quorum: 24,578,996 of 29,747,420 eligible shares represented
- All four director nominees elected through 2027; Ming Hsieh strongest support at 21,979,668 votes
- Deloitte & Touche ratified for fiscal 2026 with 24,470,414 votes for and 87,192 against
- Executive compensation approved advisory basis, 19,800,226 votes for versus 2,410,239 against
- 2026 Equity Incentive Plan approved, 18,693,758 votes for versus 3,513,983 against
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Fulgent Genetics, Inc. 8-K filings
Get the next FLGT 8-K as it lands
Follow FLGT for push alerts, or ask the research agent what this filing means.